Join
Live feed
·
INSIDERFilingvia Quantisnow
Teva Pharmaceutical Industries Limited logo

President and CEO Francis Richard D converted options into 13,043 units of Ordinary Shares and sold $211,356 worth of Ordinary Shares (6,153 units at $34.35) as part of a pre-agreed trading plan, increasing direct ownership by 0.59% to 1,177,529 units (SEC Form 4) (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
TEVA· Teva Pharmaceutical Industries Limited
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TEVA (Teva Pharmaceutical Industries Limited) and more on Quantisnow.

President and CEO Francis Richard D converted options into 13,043 units of Ordinary Shares and sold $211,356 worth of Ordinary Shares (6,153 units at $34.35) as part of a pre-agreed trading plan, increasing direct ownership by 0.59% to 1,177,529 units (SEC Form 4) (tax liability) | Quantisnow